10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $468,517 | -30.0% | 11,358 | -5.2% | 0.00% | -20.0% |
| Q2 2023 | $668,963 | -0.4% | 11,980 | -0.5% | 0.01% | 0.0% |
| Q1 2023 | $671,600 | +64.4% | 12,038 | +7.4% | 0.01% | +66.7% |
| Q4 2022 | $408,565 | +29.7% | 11,212 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $315,000 | +24.0% | 11,069 | +96.8% | 0.00% | +50.0% |
| Q2 2022 | $254,000 | -47.1% | 5,624 | +74.4% | 0.00% | -33.3% |
| Q4 2021 | $480,000 | +5.5% | 3,225 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | +33.4% | 3,126 | +79.4% | 0.00% | +50.0% |
| Q2 2021 | $341,000 | +13.3% | 1,742 | +4.8% | 0.00% | 0.0% |
| Q1 2021 | $301,000 | – | 1,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |